US 10233152
LSD1 inhibitors
granted A61PA61P11/00A61P35/00
Quick answer
US patent 10233152 (LSD1 inhibitors) held by Mirati Therapeutics, Inc. expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Mirati Therapeutics, Inc.
- Grant date
- Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P11/00, A61P35/00, A61P43/00